Jeffrey S Barrett, PhD

faculty photo
Adjunct Professor of Pediatrics
Department: Pediatrics
Graduate Group Affiliations

Contact information
The Children's Hospital of Philadelphia
Colket Translational Research Building, Room 4012
3501 Civic Center Boulevard
Philadelphia, PA 19104-4318
Office: (267) 426-5479
Fax: (267) 425-0114
BS (Chemical Engineering)
Drexel University, 1986.
MS (Pharmacokinetics)
University of Michigan, 1987.
PhD (Pharmacokinetics)
University of Michigan, 1990.
Permanent link

Selected Publications

Ince I, de Wildt SN, Peeters MYM, Burggraaf K, Jacqz-Aigrain E, Barrett JS, Danhof M, Knibbe CAJ.: Oral bioavailability of the CYP3A substrate midazolam across the human age range from preterm neonates to adults. Abstr 2853 PAGE 22 2013 Notes: []

Bai JP, Barrett JS, Burckart GJ, Meibohm B, Sachs H, Yao L.: Strategic Biomarkers for Drug Development in Treating Rare Diseases and Diseases in Neonates and Infants. AAPS J 15(2): 447-54, 2013.

McCune JS, Baker KS, Blough DK, Gamis A, Bemer MJ, Kelton-Rehkopf MC, Winter L, Barrett JS. : Prescribing patterns and pharmacokinetic-based targeting of intravenous busulfan in pediatric hematopoietic cell transplant recipients. J Clin Pharmacol 53(3): 264-75, 2013.

Della Casa Alberighi O, Barrett JS, Läer S, Meibohm B.: Response to: Physiologically Based Pharmacokinetic (PBPK) Modeling at the Extremes of Age. . Clin Pharmacol and Therapeutics 93(2): 149, 2013.

Stallings VA, Mondick JT, Schall JI, Barrett JS, Wilson M, Mascarenhas MR.: Diagnosing Malabsorption with Systemic Lipid Profiling: Pharmacokinetics of Pentadecanoic Acid and Triheptadecanoic Acid Following Oral Administration in Healthy Subjects and Subjects with Cystic Fibrosis. Int J Clin Pharmacol Therapeut 51(4): 263-73, 2013.

Barrett JS and Zuppa AF.: Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies Textbook of Pharmacoepidemiology, Second Edition. Strom BL, Kimmel SE, Hennessy S (eds.). Chichester, UK: Wiley, 2013.

Marier JF, Mangum B, Reid B, and Barrett JS.: A Modelling and Simulations Framework to Support Global Regulatory Strategies for Pediatric Drug Development Programs. Therapeutic Innovation and Regulatory Science 47(5): 550-556, 2013.

Barrett JS, McGuire J, Vezina H, Spitsin S, Douglas SD: PET measurement of receptor occupancy as a tool to guide dose selection in neuropharmacology: Are we asking the right questions? J Clin Psychopharmacol 33(6): 725-8, 2013.

Zajicek A, Fossler MJ, Barrett JS, Worthington J, Ternik R, Mclaren D, Charkoftaki G, Lum S, Breitkreutz J, Belthazar M, Mancheros P, Khan M, and Agharkar R.: Pediatric Formulations: Challenges and Potential Solutions. AAPS J 15(4): 1072-81, 2013.

Bajaj G, Dombrowsky E, Yu Q, Agarwal B, Barrett JS.: Considerations for the Prediction of Survival Time in Pancreatic Cancer Based on Registry Data. J Pharmacokinet Pharmacodyn 40: 527-36, 2013.

back to top
Last updated: 12/23/2013
The Trustees of the University of Pennsylvania